Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes

Roux‐en‐Y gastric bypass (RYGB) surgery reverses type 2 diabetes mellitus (T2DM) in approximately 80% of patients. Ghrelin regulates glucose homeostasis, but its role in T2DM remission after RYGB surgery is unclear. Nine obese T2DM subjects underwent a mixed meal tolerance test before and at 1 and 1...

Full description

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 15; no. 10; pp. 963 - 966
Main Authors Samat, A., Malin, S. K., Huang, H., Schauer, P. R., Kirwan, J. P., Kashyap, S. R.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Roux‐en‐Y gastric bypass (RYGB) surgery reverses type 2 diabetes mellitus (T2DM) in approximately 80% of patients. Ghrelin regulates glucose homeostasis, but its role in T2DM remission after RYGB surgery is unclear. Nine obese T2DM subjects underwent a mixed meal tolerance test before and at 1 and 12 months after RYGB surgery. Changes in ghrelin, body weight, glucagon‐like polypeptide‐1 (GLP‐1, glucose tolerance and insulin sensitivity (IS) were measured. At 1 month, body weight, glycaemia and IS were improved, while ghrelin concentrations were reduced (p < 0.05). After 12 months, body weight and fasting glucose were reduced (30 and 16%, respectively; p < 0.05) and IS was enhanced (threefold; p < 0.05). Ghrelin suppression improved by 32% at 12 months (p < 0.05), and this was associated with weight loss (r = 0.72, p = 0.03), enhanced IS (r = −0.78, p = 0.01) and peak postprandial GLP‐1 (r = −0.73, p = 0.03). These data suggest that postprandial ghrelin suppression may be part of the mechanism that contributes to diabetes remission after RYGB surgery.
Bibliography:ark:/67375/WNG-T6VKGQXX-M
ArticleID:DOM12118
T32 DK007319 grant
National Institutes of Health National Center for Research Resources - No. 1UL1RR024989
National Institutes of Health Grants - No. RO1 AG-12834
istex:194E429BF2EA628BC555795A947BD404CC41C013
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.12118